tradingkey.logo
搜索

Transmedics Group Inc

TMDX
添加自选
67.850USD
+1.430+2.15%
收盘 07/01, 16:00美东报价延迟15分钟
2.34B总市值
13.44市盈率 TTM

关于 Transmedics Group Inc 公司

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Transmedics Group Inc简介

公司代码TMDX
公司名称Transmedics Group Inc
上市日期May 02, 2019
CEOHassanein (Waleed H)
员工数量728
证券类型Ordinary Share
年结日May 02
公司地址200 Minuteman Road
城市ANDOVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01810
电话19785520900
网址https://www.transmedics.com/
公司代码TMDX
上市日期May 02, 2019
CEOHassanein (Waleed H)

Transmedics Group Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
5.79K
+50.48%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
3.00K
+88.95%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%

常见问题

Transmedics Group Inc的前五大股东是谁?

Transmedics Group Inc 的前五大股东如下:Dr. Waleed H. Hassanein, M.D.

有多少机构持有Transmedics Group Inc(TMDX)的股份?

截至2026Q1,共有865家机构持有Transmedics Group Inc的股份,合计持有的股份价值约为42.29M,占公司总股份的122.36%。与2025Q4相比,机构持股有所增加,增幅为-1737478.00。

哪个业务部门对Transmedics Group Inc的收入贡献最大?

在2026Q1,OCS Liver net revenue业务部门对Transmedics Group Inc的收入贡献最大,创收460.53M,占总收入的76.58%。